RETA20 (SKU: RE20)
Retatrutide
Each Vial contains 20mg of product
Retatrutide is a "triple agonist" peptide, representing the cutting edge of metabolic research. While previous generations targeted one or two receptors, Retatrutide is designed to interact with three: GLP-1, GIP, and the glucagon receptor. This triple-action approach allows researchers to study metabolic pathways from multiple angles simultaneously.
Primary Research Focus
Retatrutide is currently a major focus in laboratories investigating intensive metabolic signaling and energy balance:
The "Triple Action" Effect: Scientists use Retatrutide to study how the body responds when three hunger and energy hormones are triggered at once. Research suggests this combination may be significantly more potent for metabolic signaling than single or dual-action peptides.
Energy Output (Thermogenesis): A unique aspect of Retatrutide research is the inclusion of the glucagon receptor. Researchers are investigating how this specifically signals the body to increase energy expenditure and "burn" through stored fuel, rather than just reducing intake.
Fat Metabolism & Liver Health: Significant study is being directed toward how Retatrutide influences lipid (fat) processing. This includes its potential role in reducing fat accumulation within the liver and improving overall metabolic "flexibility."
Satiety & Cravings: Like other incretin mimetics, it is used to model how the brain receives fullness signals, with a focus on how the triple-receptor approach might eliminate "food noise" or intense cravings more effectively in test subjects.